The FTC’s existing action, proclaimed on Tuesday, Settled charges against Concordia Pharmaceuticals and Par Pharmaceutical over the add, adhd Hyperactivity Disorder drug Kapvay. Unlike the earlier $1.2 billion settlement with Teva Pharmaceutical Industries over delaying generics of the sleep disorder drug Provigil from coming to market, This settlement did not have a fiscal penalty attached. […]